dont be fooled, page-10

yeah sorry patrickm, you are dead wrong about the options mate. Go back through the announcements and look at the 30-40 3B announcements and you will see that most of those 1.2c options were converted at different times throughout the year. There is no big glut of options that have just been converted as most would have been absorbed throughout the year.

I personally believe this coupled with the resigning director selling, is why we have a great opportunity to top up sub $0.05.

The best thing about this stock is there are so many negotiations in progress that any day we could get an announcement about a new deal.

In my opinion most of the risk is gone out of ADO since Merck and Bangs both tested the product and signed deals. It is only a matter of sitting and waiting for everyone else to catch up and sign on too.